Xospata (gilteritinib)

pCPA File Number: 21257
Negotiation Status:
Concluded with an LOI
Indication(s):
Acute Myeloid Leukemia (AML)
Sponsor/Manufacturer:
Astellas Pharma Inc.
CDA-AMC Project Number:
PC0202-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: